 |
PDBsum entry 3dcv
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
4-(1h-Indazol-5-Yl)-6-Phenylpyrimidin-2(1h)-One analogs as potent cdc7 inhibitors.
|
 |
|
Authors
|
 |
C.M.Shafer,
M.Lindvall,
C.Bellamacina,
T.G.Gesner,
A.Yabannavar,
W.Jia,
S.Lin,
A.Walter.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2008,
18,
4482-4485.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
A series of 4-(4-hydroxyphenyl)-6-phenylpyrimidin-2(1H)-ones were identified by
HTS as inhibitors of CDC7. Molecular modeling and medicinal chemistry techniques
were employed to explore the SAR for this series with a focus on removing
potential metabolic liabilities and improving cellular potency.
|
 |
|
|
|
|
 |